Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Replimune Group, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 101 | 1 | 99 | −1 |
| Shares | 35.4M | 32 | 38.8M | +3.48M (+9.8%) |
| Value | $1.05B | $0 | $1.05B | +$2.77M (+0.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Replimune Group, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 3,209,627 | $87.0M | 7.99% |
| Point72 Asset Management, L.P. | 340,200 | $9.22M | 0.04% |
| Renaissance Technologies LLC | 46,653 | $1.26M | 0.00% |
| Harbor Capital Advisors, Inc. | 37,105 | $1.01M | 0.37% |
| HRT Financial LP | 34,703 | $940.0K | 0.01% |
| Natixis | 19,200 | $520.0K | 0.00% |
| Mesirow Financial Investment Management, Inc. | 15,326 | $415.0K | 1.20% |
| Ergoteles LLC | 13,927 | $377.0K | 0.01% |
| Quantbot Technologies LP | 600 | $16.0K | 0.00% |
| CWM, LLC | 27 | $1.00K | 0.00% |
| Covestor Ltd | 16 | $0 | 0.00% |
Sold out (12)
Institutions that held Replimune Group, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Alberta Investment Management Corp | 50,000 | $1.48M |
| Prudential Financial Inc | 19,240 | $570.0K |
| Principal Financial Group Inc | 9,232 | $274.0K |
| DuPont Capital Management Corp | 8,167 | $242.0K |
| Dynamic Technology Lab Private Ltd | 7,329 | $217.0K |
| Qube Research & Technologies Ltd | 7,131 | $211.0K |
| Altshuler Shaham Ltd | 4,093 | $122.0K |
| Group One Trading, L.P. | 1,794 | $53.0K |
| O'Shaughnessy Asset Management, LLC | 1,202 | $36.0K |
| Penserra Capital Management LLC | 1,070 | $31.0K |
| Federation des caisses Desjardins du Quebec | 485 | $14.4K |
| TCI Wealth Advisors, Inc. | 76 | $2.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Replimune Group, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 32 | $0 |